Literature DB >> 6847263

Cell-mediated immunity to myoglobin in polymyositis.

R Herrera-Esparza, L Magaña, J Moreno, A Fraga, C Lavalle.   

Abstract

Using the leucocyte migration inhibition (LIF) test we looked for evidence of cell-mediated hypersensitivity against myoglobin in 8 patients with polymyositis (PM) or dermatomyositis (DM). The migration index for PM-DM patients was 47.5 +/- 17%, while in the controls the index was 86 +/- 12% (p less than 0.001). The presence of serum antibodies against myoglobin was also investigated by passive haemagglutination (PH) and counterimmunoelectrophoresis (CIE). By PH the reciprocal titre of antimyoglobin antibodies was 150 +/- 28 in PM-DM compared with 16.2 +/- 15.9 and 8.7 +/- 7.7 in control patients with diseases (p less than 0.01) and negative in normal persons. CIE showed antimyoglobin antibodies in 3 PM-DM patients and in none of controls. Cell-mediated immunity against myoglobin may be implicated in the pathogenesis of PM. The pathological significance of antimyoglobin antibodies remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6847263      PMCID: PMC1001096          DOI: 10.1136/ard.42.2.182

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  23 in total

1.  Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy.

Authors:  J N Whitaker; W K Engel
Journal:  N Engl J Med       Date:  1972-02-17       Impact factor: 91.245

2.  Lymphocyte sensitivity to skeletal muscle in patients with polymyositis and other disorders.

Authors:  M M Esiri; I C MacLennan; B L Hazleman
Journal:  Clin Exp Immunol       Date:  1973-05       Impact factor: 4.330

3.  Cell-mediated cytotoxicity to muscle in polymyositis. Effect of immunosuppression.

Authors:  R L Dawkins; F L Mastaglia
Journal:  N Engl J Med       Date:  1973-03-01       Impact factor: 91.245

Review 4.  A leucocyte migration technique for in vitro detection of cellular (delayed type) hypersensitivity in man.

Authors:  G Bendixen; M Soborg
Journal:  Dan Med Bull       Date:  1969-01

5.  Dermatomyositis. Adenocarcinoma of male breast. Detection of antibodies to the neoplasm in the serum.

Authors:  P W Copeman; S Alexander
Journal:  Proc R Soc Med       Date:  1967-02

6.  Lymphocyte stimulation with muscle homogenate in polymyositis and other muscle-wasting disorders.

Authors:  M Saunders; M Knowles; S Currie
Journal:  J Neurol Neurosurg Psychiatry       Date:  1969-12       Impact factor: 10.154

7.  Rapid detection of Australia antigen by counterimmunoelectrophoresis.

Authors:  D J Gocke; C Howe
Journal:  J Immunol       Date:  1970-04       Impact factor: 5.422

8.  Lymphotoxin formation by lymphocytes and muscle in polymyositis.

Authors:  R L Johnson; C W Fink; M Ziff
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808

9.  Studies on human myoglobin. I. Myoglobin in sickle cell disease.

Authors:  K SINGER; B ANGELOPOULOS; B RAMOT
Journal:  Blood       Date:  1955-10       Impact factor: 22.113

10.  Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF).

Authors:  R E Rocklin
Journal:  J Immunol       Date:  1974-04       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.